Description
Mirtazapine (mirtazapine) is a mental health medications agent listed in our Mental health medications directory and prescribed for depression (1.1) (2.1). Administered via the oral route, Mirtazapine is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Mirtazapine is a medication containing the active pharmaceutical ingredient mirtazapine, classified pharmacologically as a mental health medications agent (2.1). It is clinically indicated for the management of depression as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Mental health medications section of our catalogue, patients and prescribers frequently review Mirtazapine alongside related therapies such as Remeron (Mirtazapine), Abilify (Aripiprazole), Amitriptyline, and Amoxapine.
Official Indications and Usage
Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults. (1.1)
Mechanism of Action and Pharmacology
The mechanism of action of mirtazapine for the treatment of major depressive disorder, is unclear. However, its efficacy could be mediated through its activity as an antagonist at central presynaptic α 2 adrenergic inhibitory autoreceptors and heteroreceptors and enhancing central noradrenergic and serotonergic activity. (1.1)
What is Depression?
Depression affects mood, interest, thinking, and daily function. Treatment can involve therapy, medicines, and follow-up tailored to the individual. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Depression condition guide for appointment questions and related therapies (2.1).
Ordering Mirtazapine from Canada for U.S. Delivery
U.S. patients can order Mirtazapine (Mirtazapine) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Mirtazapine |
| Chemical / Generic Name | Mirtazapine |
| Pharmacological Class | Mental health medications agent |
| Therapeutic Category | Mental health medications |
| Same-Ingredient Catalogue Entries | Remeron (Mirtazapine) |
| Molecular Formula | C17H19N3 (2.1) |
| Molecular Weight | 265.35. g/mol (2.1) |
| Bioavailability | ~50% (1.1) |
| Protein Binding | ~85% (1.1) |
| Elimination Half-Life | ~20 to 40 hours (1.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus |
| Routes of Administration | Oral |
| Dosage Forms & Strengths | Mirtazapine Tablets, USP are supplied as: 7.5 mg tablets: Yellow colored, round, biconvex film-coated tablets debossed with “886” on one side and “N” on |
| Primary Indications | Depression |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| FDA UNII Identifier | A051Q2099Q |
| NLM RxNorm Concept ID (RxCUI) | 476809 |
| FDA Application License | ANDA219919 |
| Official DailyMed SetID | 63f140c2-2a18-4dea-96fe-2658dda28a0c |
| Catalogue Index Links | Letter M Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
Starting dose: 15-mg once daily; may increase up to maximum recommended dose of 45 mg once daily. Administer orally once daily, preferably in the evening prior to sleep. Reduce dose gradually when discontinuing mirtazapine tablets. (1.1)
Presentations and Strengths
Mirtazapine Tablets, USP are supplied as: 7.5 mg tablets: Yellow colored, round, biconvex film-coated tablets debossed with “886” on one side and “N” on the other side, free from physical defects 15 mg tablets: Yellow colored, oblong, biconvex film-coated tablets, functionally scored on one side and debossed with “N 887” on the other side, free from physical defects 30 mg tablets: Brown colored, oblong, biconvex film-coated tablets, functionally scored on one side and debossed with “N 888” on the other side, free from physical defects 45 mg tablets: White to off white colored, oblong, biconvex film-coated tablets debossed with “N 889” on one side and plain on the other side, free from physic. (1.1)
Administration Guidance
Take Mirtazapine orally at the same time(s) each day as directed on your prescription label (1.1). Check with your pharmacist whether your specific formulation should be taken with a meal or on an empty stomach, and swallow extended-release or film-coated tablets whole without crushing, chewing, or splitting unless the tablet is scored and your prescriber has instructed you to do so.
Missed Dose Guidance
If you miss a scheduled dose of Mirtazapine, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Mirtazapine is mirtazapine (2.1). Other catalogue entries containing mirtazapine include Remeron (Mirtazapine).
Inactive Ingredients (Excipients)
According to the U.S. FDA product labeling, formulation excipients include lactose monohydrate, corn starch, low substituted hydroxypropyl cellulose, hydroxypropyl cellulose, colloidal silicon dioxide, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol (1.1). Inactive ingredients can vary slightly between different manufacturers and international or generic presentations; review the dispensed carton if you have known excipient sensitivities.
Cautions and important safety information
Boxed Warning
Warning: suicidal thoughts and behaviors Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors. Mirtazapine tablets are not approved for use in pediatric patients. (1.1)
Contraindications
Mirtazapine tablets are contraindicated in patients: Taking, or within 14 days of stopping, MAOIs (including the MAOIs linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome. With a known hypersensitivity to mirtazapine or to any of the excipients in mirtazapine tablets. Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome, bullous dermatitis, erythema multiforme and toxic epidermal necrolysis have been reported following the use of mirtazapine tablets. Concomitant use of monoamine oxidase inhibitors (MAOIs) or use within 14 days of stopping MAOIs. (1.1)
Key Clinical Precautions
Before starting or continuing Mirtazapine, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Suicidal ideation and behavior monitoring: Patients, especially children, adolescents, and young adults starting or changing doses of centrally acting therapies, should be closely monitored for worsening mood, agitation, or emergence of suicidal thoughts.
- Cardiovascular events: Depending on the medication class and underlying medical history, patients should be monitored for signs of cardiovascular events such as chest pain, shortness of breath, sudden weakness, or slurred speech.
- Cardiac conduction and QT interval: Caution is advised in patients with known arrhythmias, bradycardia, electrolyte disturbances (hypokalemia or hypomagnesemia), or concomitant QT-prolonging medications.
- Serotonin syndrome: Concomitant use with other serotonergic agents (SSRIs, SNRIs, triptans, MAOIs, linezolid, tramadol, or St. John’s wort) can precipitate potentially life-threatening serotonin syndrome (agitation, rapid heart rate, muscle twitching, fever).
- Seizure threshold: This medication may lower the seizure threshold or require caution in patients with a history of seizure disorders or conditions that predispose to seizures.
- Hematologic monitoring (cytopenias): Periodic complete blood counts (CBC) may be required to monitor for neutropenia, anemia, or thrombocytopenia.
Pregnancy, Lactation, and Special Populations
Prolonged experience with mirtazapine in pregnant women, based on published observational studies and postmarketing reports, has not reliably identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. There are risks associated with untreated depression in pregnancy. In animal reproduction studies, oral administration of mirtazapine to pregnant rats and rabbits during the period of organogenesis revealed no evidence of teratogenic effects up to 20 and 17 times the maximum recommended human dose (MRHD) of 45 mg, respectively, based on mg/m 2 body surface area. (1.1)
Interactions
Official Drug Interaction Overview
Clinically Important Drug Interactions with Mirtazapine Tablets Monoamine Oxidase Inhibitors (MAOIs) Clinical Impact The concomitant use of serotonergic drugs, including mirtazapine tablets, and MAOIs increases the risk of serotonin syndrome. Intervention Mirtazapine tablets are contraindicated in patients taking MAOIs, including MAOIs such as linezolid or intravenous methylene blue. Examples selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue Other Serotonergic Drugs Clinical Impact The concomitant use of serotonergic drugs with mirtazapine tablets increases the risk of serotonin syndrome. Intervention Monitor patients for signs and symptoms of serotonin syndrome, particularly during treatment initiation and dosage increases. If serotonin syndrome occurs, consider discontinuation of mirtazapine tablets and/or concomitant serotonergic drugs. (1.1)
Important Interaction Categories
Concomitant use of Mirtazapine with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Warfarin and vitamin K antagonists (such as Coumadin (Warfarin Sodium) or Warfarin Generic in our Cardiovascular directory): Concomitant administration may alter prothrombin time and International Normalized Ratio (INR) or have additive effects on hemostasis and bleeding risk. More frequent INR monitoring and clinical observation for bleeding are recommended.
- Lithium: This medication may alter renal lithium clearance, either increasing serum lithium levels (risking lithium toxicity) or decreasing lithium concentrations (reducing therapeutic efficacy). Serum lithium levels should be monitored closely when starting, adjusting, or stopping therapy.
- Monoamine oxidase inhibitors (MAOIs, such as phenelzine, tranylcypromine, selegiline, or linezolid): Concomitant use or use within 14 days of stopping an MAOI can cause severe drug interactions, including hypertensive crisis, serotonin syndrome, or enhanced hypoglycemic and central nervous system effects.
- Strong CYP3A4 inhibitors and inducers (such as ketoconazole, itraconazole, clarithromycin, ritonavir, rifampin, carbamazepine, phenytoin, or St. John’s wort): Co-administration with strong CYP3A4 inhibitors can significantly increase plasma concentrations and side-effect risk, whereas CYP3A4 inducers can decrease systemic exposure and reduce efficacy.
Side effects
Like all medications, Mirtazapine can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Constipation: Adequate hydration and dietary fiber can help manage mild changes in bowel habits.
- Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
- Drowsiness or somnolence: Use caution with driving or tasks requiring alertness until you know how this medication affects you.
Clinical Trial and Postmarketing Adverse Reactions
The following adverse reactions are described in more detail in other sections of the prescribing information: Hypersensitivity Suicidal Thoughts and Behaviors Agranulocytosis Serotonin Syndrome Angle-Closure Glaucoma QT Prolongation and Torsades de Pointes Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Increased Appetite and Weight Gain Somnolence Activation of Mania or Hypomania Seizures Elevated Cholesterol and Triglycerides Hyponatremia Transaminase Elevations Discontinuation Syndrome Use in Patients with Concomitant Illness Most common adverse reactions (≥5% or greater and twice placebo) were somnolence, increased appetite, weight gain, and dizziness. (1.1)
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Mirtazapine Tablets, USP are supplied as: Tablet Strength Tablet Color/Shape Tablet Markings Package Configuration NDC Code 7.5 mg Yellow colored, round, biconvex film-coated tablets Debossed with “886” on one side and “N” on the other side, free from physical defects Blistercards of 30 Blistercards of 15 0615-8663-39 0615-8663-05 15 mg Yellow colored, oblong, biconvex film-coated tablets Functionally scored on one side and debossed with “N 887” on the other side, free from physical defects --- --- 30 mg Brown colored, oblong, biconvex film-coated tablets Functionally scored on one side and debossed with “N 888” on the other side, free from physical defects --- --- 45 mg White to off white colored, oblong, biconvex film-coated tablets Debossed with “N 88. (1.1)
Store Mirtazapine in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).
What is a generic drug?
A generic medication contains the exact same active pharmaceutical ingredient (mirtazapine) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.
While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.
Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Mental health medications directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.
Related Medications in Our Catalogue
- Remeron (Mirtazapine), listed in Mental health medications
- Abilify (Aripiprazole), listed in Mental health medications
- Amitriptyline, listed in Mental health medications
- Amoxapine, listed in Mental health medications
- Anafranil (Clomipramine Hydrochloride), listed in Mental health medications
- Antabuse (Disulfiram), listed in Mental health medications
Related Categories, Directories, and Ordering Guides
- Mental health medications Category Directory
- Medications Starting with M
- Active Ingredient Directory
- What to prepare before a prescription order
- How to compare prescription prices without mixing up the product
- How to Order Prescription Medication
- Prescription Requirements
- Ordering Medication from Canada Guide
- Caregiver Ordering Guide
- Explore Medications
- Explore Categories
- Explore Coumadin Warfarin Sodium
- Explore Warfarin Generic
- Explore Cardiovascular
Frequently Asked Questions About Mirtazapine
What is Mirtazapine and what active ingredient does it contain?
Mirtazapine is a mental health medications agent containing the active pharmaceutical ingredient mirtazapine. It is supplied for oral administration and requires a valid prescription where applicable.
How does Mirtazapine work in the body?
The mechanism of action of mirtazapine for the treatment of major depressive disorder, is unclear. However, its efficacy could be mediated through its activity as an antagonist at central presynaptic α 2 adrenergic inhibitory autoreceptors and heteroreceptors and enhancing central noradrenergic and serotonergic activity.
What conditions is Mirtazapine prescribed to treat?
Mirtazapine is primarily indicated for depression. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Mirtazapine?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Mirtazapine is administered via the oral route. Take it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Mirtazapine?
Commonly reported side effects of Mirtazapine include feeling sick, vomiting, constipation, headache, dizziness, and sleepiness. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Mirtazapine?
Important interaction categories for Mirtazapine include warfarin, lithium, monoamine oxidase inhibitors, and medicines that strongly affect CYP3A enzymes. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Mirtazapine be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Mirtazapine to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Mirtazapine online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Mirtazapine (Mirtazapine) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
What is the brand-name version of Mirtazapine (Mirtazapine) at a Canada pharmacy?
Yes. Mirtazapine is the bioequivalent generic formulation of brand-name Remeron, containing the same active ingredient (Mirtazapine) and strength options.
Brand: Remeron
How is Mirtazapine shipped to U.S. residents, and how much does shipping cost?
Mirtazapine ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Mirtazapine prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Mirtazapine prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Mirtazapine are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Mirtazapine. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) MedlinePlus Medical Encyclopedia: Depression. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (3.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
